Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $808.6400 (0.97%) ($800.1500 - $808.6400) on Wed. Nov. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.04% (three month average) | RSI | 34 | Latest Price | $808.6400(0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(52%) SDY(52%) SPLV(45%) XLU(43%) XLV(43%) | Factors Impacting REGN price | REGN will decline at least -0.52% in a week (0% probabilities). USO(-33%) ONLN(-30%) VXX(-28%) UNG(-25%) XLE(-24%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.52% (StdDev 1.04%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $800.93(0.96%) | 10 Day Moving Average | $799.65(1.12%) | 20 Day Moving Average | $804.3(0.54%) | To recent high | -4.4% | To recent low | 4.3% | Market Cap | $85.739b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |